Biosimilar Manufacturing solution center

1. You Are Never Too Small To Think Big! 6/8/2020

   Your automation platform can expand with your business if you consider design choices in the initial stages. Early platform design choices can greatly affect speed to market and regulatory compliance.

2. Can Biosimilars Be The Bridge To More Widespread Continuous Bioprocessing? 5/19/2020

   This article will examine the relationship between improved continuous manufacturing (CM) and biosimilar development, paying particular attention to the reasons why biosimilars are especially promising candidates for CM development and innovation.

3. Business Continuity Program Helps Maintain Operations In The Face Of Crisis 5/5/2020

   Get insights into implementing a robust business continuity management program that can help secure supply, reduce risks, and maintain quality in manufacturing operations, through a crisis situation.

4. Automated High Throughput mAb Purification Using Fibro Technology 4/21/2020

   Biomanufacturing is trending towards higher numbers of monoclonal antibody (mAb) projects and smaller batch sizes, with production of most mAbs below 100 kg/yr. These trends are fueling demands to screen more clones faster and improve the efficiency of process development (PD). Read how the Fibro PrismA unit provides a time advantage with comparable recovery and product quality attributes to resin-based column.

5. Standardization Is Key To Building A Successful Global Business Strategy 4/15/2020

   Standardized approaches to biomanufacturing can lower costs, improve outcomes and alter the landscape of the global pharmaceutical market.

6. Increasing Productivity In Hydrophobic Interaction Chromatography 2/27/2020

   In this study, the hydrophobicities of newer generation Capto HIC resins were compared to Sepharose High Performance and Sepharose Fast Flow HIC resins.

7. Pairing Data Connectivity, Automation Ease Tech Transfer/Scale-Up 2/11/2020

   In biopharma, process data is used in many ways throughout process development and production phases. This article outlines how connectivity and comprehensive automation ease tech transfer and scale up.

8. Securing Today’s Biomanufacturing Supply Chain Using Transformative Supply 1/10/2020

   Managing today’s supply chain complexity begins by transforming historically transactional relationships to those that drive suppliers to value-added status, working toward shared customer goals.

9. Fresenius Kabi: The Quest For More Efficient Biosimilar R&D 1/6/2020

   Following the news of Fresenius Kabi’s new biosimilar R&D lab, I reached out to one executive to discuss the current challenges in biosimilar R&D, including maintaining the delicate balance between biosimilar R&D and commercial teams as Fresenius Kabi prepares for a long future in the biosimilar space.

10. A Biopharma Year In Review — And A Look Ahead To 2020 12/16/2019

    The industry has shown surprising resilience and consistency, emerging relatively unscathed from the recession at the beginning of the past decade. Capacity and expansion were relatively unaffected and continue to draw investors seeking healthy returns and a recession-resistant risk profile.